Search Results

All Content Formulary Only Other Content

Scottish Formulary has compiled the following search results: We have found 9 results when searching "Levetiracetam"

DOCUMENT

Apr 2021 - LJF Summary of Amendments

Prepared May 2021 DM/ZH Summary of Lothian Joint Formulary Amendments The purpose of this summary is to detail the main changes to the LJF sections and provide additional information on the reasons f...

FORMULARY DECISION

Levetiracetam : Keppra

150/04 : Epilepsy. See link to SMC advice for full details of restriction.

FORMULARY DECISION

Levetiracetam : Keppra

151/04 : Epilepsy. See link to SMC advice for full details of restriction.

FORMULARY DECISION

Levetiracetam : Keppra

311/06 : Epilepsy

FORMULARY DECISION

Levetiracetam : Keppra

394/07 : Adjunctive therapy in treatment of partial onset seizures with or without sedondary generalisation in children from 4 years of age with epilepsy

FORMULARY DECISION

Levetiracetam : Keppra

395/07 : Adjunctive therapy in treatment of myclonic seizures in adults and adolescents from 12 years of age with juvenile muclonic epilepsy

FORMULARY DECISION

Levetiracetam : Keppra

396/07 : Adjunctive therapy in treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with generalised idiopathic epilepsy

FORMULARY DECISION

Levetiracetam : Keppra

397/07 : Monotherapy for epilepsy

FORMULARY DECISION

Levetiracetam : Keppra

661/10 : Adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in children and infants from 1 month of age to 4 years with epilepsy